We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Device Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » BAXTER HEALTHCARE SIGNS CONSENT DECREE FOR CGMP VIOLATIONS IN MAKING INFUSION PUMPS

BAXTER HEALTHCARE SIGNS CONSENT DECREE FOR CGMP VIOLATIONS IN MAKING INFUSION PUMPS

July 3, 2006

Baxter Healthcare has signed a consent decree with the FDA related to violations of current good manufacturing practices (cGMPs) in making two brands of infusion pumps, the agency said June 29.

Under the agreement approved by the U.S. District Court for the Northern District of Illinois, Baxter will stop manufacturing and distributing all models of its Colleague volumetric infusion pump and Syndeo patient controlled analgesic syringe pump in the U.S. until:It corrects manufacturing deficiencies; andThe devices are made in compliance with the FDA's cGMP requirements and quality systems regulation (QSR).

Infusion pumps are electronic devices used for intravenous and other forms of drug delivery. They provide medication in a continuous or intermittent manner for a prolonged period of time, the FDA said. "If they don't work properly, patients are put at risk," said Daniel Schultz, director of the FDA's Center for Devices and Radiological Health.

The FDA April 28 issued recommendations for healthcare providers and biomedical engineers to take additional safety steps beyond those issued by the manufacturer when using Baxter's Colleague pump.

The device "has exhibited a variety of problems, including under-infusion, battery failures, false alarms and failure to alarm," the agency said. ()a href="http://www.fdanews.com/ddl/33_27/" target=_blank>

KEYWORDS FDAnews Device Daily Bulletin

Upcoming Events

  • 10Mar

    FDA Drug GMP Facility Inspections During the Pandemic

  • 16Mar

    Pharmaceutical Naming Regulation: Understanding the Latest Developments

  • 18Mar

    Pharmaceutical Postmarket Surveillance: Latest Developments in the Era of COVID-19

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 30Mar

    Data Integrity for GMP/Postmarket Professionals: Core Requirements, Expectations and Challenges

  • 06Apr

    Medical Device Cybersecurity: Understand the Latest Developments

Featured Products

  • Biological Risk Evaluation and Management for Medical Devices

  • GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

  • Effective text

    Pfizer/BioNTech Vaccine Equally Effective for All Age Groups, Israeli Study Says

  • Siemens Healthineers logo

    Siemens Healthineers’ COVID-19 Antigen Lab Test Receives CE Mark

  • UKflag.jpg

    UK Study Says Single Shot of Pfizer/BioNTech Vaccine Significantly Lessened Asymptomatic Infections

  • emergency use authorization approved

    Eurofins Receives FDA Emergency Authorization for Over-the-Counter COVID-19 Test

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing